TMC Life Sciences suspends GCEO; appoints temporary replacement


TMC Life Sciences Bhd group CEO Dr Melvin Heng Jun Li

PETALING JAYA: TMC Life Sciences Bhd has appointed director Dr Melvin Heng Jun Li as its group chief executive officer (GCEO) with immediate effect, following the suspension of Wan Nadiah Wan Mohd Abdullah Yaakob.

In a filing with Bursa Malaysia, the company said Wan Nadiah was also suspended as CEO of Thomson Hospitals Sdn Bhd, resulting in the powers, authorities and functions vested in her as the GCEO and CEO to be suspended with effect from Jan 29, 2024 until further announcement by the board.

Follow us on our official WhatsApp channel for breaking news alerts and key updates!
TMC Life Sciences , CEO , Melvin Heng Jun Li ,

Next In Business News

Reading the market signals
Urban harmony: Can stakeholders row together?
Breathing new life into forgotten spaces
FROM BANGSAR TO BEYOND
Asia to lead next AI wave
Luxury real estate trends in 2026
China’s gold rush continues
SC Estate Builder’s hotel acquisition under scrutiny
Department stores bet on experiences
Jakarta set to rise

Others Also Read